Mannitolo Bioindustria L.I.M.

Mannitol, the active ingredient in Mannitolo Bioindustria L.I.M., is an osmotic diuretic presented as a sterile intravenous solution for hospital use. It is employed to lower elevated intracranial pressure and to stimulate diuresis in patients with acute renal failure or toxin overload, and to facilitate the renal clearance of certain toxic substances.

GNH USA supplies Mannitolo Bioindustria L.I.M. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and intensive‑care units worldwide, with a focus on quality‑assured bulk and unit‑dose deliveries.

Mannitol is used as an osmotic agent in several acute medical conditions where rapid fluid shifts are required.

Intracranial hypertension: reduces intracranial pressure by drawing water out of brain tissue into the vascular compartment. Acute renal failure: promotes diuresis to enhance urine output and aid renal clearance. Toxin elimination: facilitates renal excretion of nephrotoxic substances by increasing glomerular filtration.

Mannitol may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache - Nausea or vomiting - Electrolyte imbalance, especially hypernatremia - Transient hypotension - Mild renal tubular irritation

Serious or Rare Side Effects: - Acute renal failure - Pulmonary edema - Severe allergic reactions or anaphylaxis - Marked electrolyte disturbances (e.g., severe hyponatremia) - Hemolysis in susceptible individuals

When using Mannitol, clinicians should observe several safety measures.

Renal function: assess baseline creatinine and monitor urine output. Electrolyte monitoring: check serum sodium, potassium and osmolality regularly. Cardiac status: evaluate for heart failure before administration. Fluid balance: avoid excessive volume overload during infusion. Pregnancy: use only if potential benefit justifies the risk. Store at ambient temperature: keep in original container, protect from light and moisture.

Mannitol can interact with other medications, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause severe dehydration. - Nephrotoxic antibiotics (e.g., aminoglycosides): increased risk of renal injury. - Insulin: may potentiate hypoglycemia due to altered glucose distribution.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor potassium levels and blood pressure. - Lithium: risk of toxicity due to altered renal clearance. - Antihypertensives: possible additive hypotensive effect.